Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5 8% After Analyst Upgrade dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $23.42, but opened at $22.81. Tarsus Pharmaceuticals shares last traded at $23.36, with a volume of 57,660 shares trading hands. Analyst Upgrades and Downgrades Several brokerages recently weighed in on TARS. […]
Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $42 00 Price Target at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
William Blair assumed coverage on shares of Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $44.00 price objective on the stock. William Blair also issued estimates for Tarsus Pharmaceuticals’ Q2 2023 earnings at ($1.07) EPS, Q3 2023 […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 1,570,000 shares, an increase of 72.6% from the May 31st total of 909,800 shares. Approximately 8.0% of the company’s shares are sold short. Based […]